Jobs in Lenexa, KS
The Lenexa site is one of our Centers of Excellence focused on manufacturing cell culture media products. In the Biopharmaceutical Industry, there are limited companies which can state we have been here since the start. We can. Whether it is providing cell culture platform medias, custom manufacturing capabilities, or innovative raw materials, we meet the ever-changing demands associated with this critical raw material supply.
Our cell culture media programs focus on security of supply, identifying and managing variability, and improving safety within the prevailing supply chains. Our years of experience show in the way we tailor our abilities to meet our customer’s needs and stand as the foundation for our SAFC Brand. Lenexa mainly produces dry powder cell culture media used in the Biotherapeutic process.
Our site has been a beacon of employment in Lenexa, KS for over 30 years. With room for site expansion, our business is strong and growing. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.
Are you curious
Watch our video and find out more about working for our manufacturing cell culture media products for the pharmaceutical business.
Rafael Zagato, Director Site Operations
"We're looking for an innovative, dedicated and vibrant people to help us fulfill our site mission to improve patient lives."
MilliporeSigma's Curiosity Cube®
Making a difference
We offer benefits in three areas:
- Company Benefits such as company retirement plans or flexible working models
- Health & Well-Being Benefits
- Services for Life, our platform to provide support or self-service for individual needs
Click here to learn more about our benefits.
Every year we publish an in-depth report about our sustainability achievements and efforts in the field of corporate responsibility. We engage in three strategically important areas, namely Global Health, Sustainable Solutions as well as Broad Minds.
Click here to learn more about our benefits Corporate Responsibility Report 2021.